| 000 | 01688 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514160830.0 | ||
| 264 | 0 | _c20031210 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 024 | 7 |
_a10.1124/jpet.102.052688 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarraway, Robert E | |
| 245 | 0 | 0 |
_aCa2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cNov 2003 |
||
| 300 |
_a640-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCalcium _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aEndocytosis |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInositol Phosphates _xmetabolism |
| 650 | 0 | 4 | _aIodine Radioisotopes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurotensin _xmetabolism |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 650 | 0 | 4 | _aPhotoaffinity Labels |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xpathology |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Neurotensin _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aGui, Xianyong | |
| 700 | 1 | _aCochrane, David E | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 307 _gno. 2 _gp. 640-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.102.052688 _zAvailable from publisher's website |
| 999 |
_c14313337 _d14313337 |
||